Frozen shoulder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with frozen shoulder; 2. Meet the pain stage in the staging standard of frozen shoulder; 3. Those who did not take other related treatment drugs (such as oral diclofenac sodium sustained-release tablets, loxoprofen sodium tablets, etc.) within 4 weeks before screening and did not receive other treatment methods; 4. Aged 30-70 years old (including 30 years old and 70 years old); 5. Subjects voluntarily agreed to participate in this study and signed a written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who have received relevant treatment in the past, or there may be effect indicators that may affect this study; 2. Patients with acute soft tissue injury of shoulder, infectious inflammation, fracture, dislocation, rheumatoid arthritis, etc.; 3. Patients with serious primary diseases such as diabetes, tumors, cardiovascular and cerebrovascular diseases, blood diseases, and mental illnesses; 4. Those who have a history of allergies to the drugs in this study in the past; 5. Other situations in which the investigator considers it inappropriate to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Index Score;Shoulder CMS Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Application satisfaction;Adverse event rate; | — |
Countries
China
Contacts
the Second Xiangya Hospital of Central South University